Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dairy Products | 3 | 2021 | 498 | 1.270 |
Why?
|
Vitamin D | 8 | 2014 | 3223 | 0.920 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2023 | 11725 | 0.890 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2021 | 402 | 0.680 |
Why?
|
Diabetes Mellitus | 7 | 2023 | 5751 | 0.640 |
Why?
|
Glycemic Index | 2 | 2019 | 395 | 0.620 |
Why?
|
Diet, Fat-Restricted | 1 | 2020 | 320 | 0.610 |
Why?
|
Nutrition Assessment | 1 | 2021 | 723 | 0.610 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2019 | 378 | 0.550 |
Why?
|
Hyperglycemia | 5 | 2024 | 1373 | 0.530 |
Why?
|
Leukemia | 2 | 2012 | 1511 | 0.460 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2012 | 1381 | 0.440 |
Why?
|
Calcium, Dietary | 2 | 2011 | 526 | 0.400 |
Why?
|
Overweight | 4 | 2018 | 2371 | 0.370 |
Why?
|
Lipids | 2 | 2023 | 3305 | 0.360 |
Why?
|
Body Weight | 4 | 2021 | 4669 | 0.360 |
Why?
|
Diabetes, Gestational | 1 | 2019 | 1184 | 0.360 |
Why?
|
Blood Glucose | 7 | 2023 | 6256 | 0.340 |
Why?
|
Dyslipidemias | 1 | 2016 | 849 | 0.340 |
Why?
|
Endocrinology | 2 | 2014 | 443 | 0.320 |
Why?
|
Feeding Behavior | 1 | 2019 | 3188 | 0.290 |
Why?
|
Obesity | 5 | 2020 | 12745 | 0.270 |
Why?
|
Cardiovascular Diseases | 7 | 2022 | 15165 | 0.270 |
Why?
|
Dietary Supplements | 4 | 2014 | 3297 | 0.250 |
Why?
|
Diet | 2 | 2021 | 7939 | 0.250 |
Why?
|
Insulin Resistance | 3 | 2014 | 3864 | 0.230 |
Why?
|
Vitamins | 2 | 2014 | 1622 | 0.230 |
Why?
|
Insulin-Secreting Cells | 1 | 2011 | 891 | 0.230 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2013 | 1378 | 0.230 |
Why?
|
Risk Factors | 16 | 2022 | 72290 | 0.230 |
Why?
|
Energy Intake | 2 | 2020 | 2148 | 0.210 |
Why?
|
Aerobiosis | 1 | 2020 | 106 | 0.190 |
Why?
|
Fenofibrate | 1 | 2020 | 88 | 0.180 |
Why?
|
Insulin | 3 | 2011 | 6580 | 0.180 |
Why?
|
Hypoglycemic Agents | 2 | 2009 | 2872 | 0.180 |
Why?
|
Malaysia | 1 | 2019 | 92 | 0.180 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7279 | 0.170 |
Why?
|
Weight Gain | 1 | 2009 | 2292 | 0.170 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 3336 | 0.170 |
Why?
|
Hypertension | 2 | 2016 | 8480 | 0.160 |
Why?
|
Diet Therapy | 1 | 2019 | 154 | 0.160 |
Why?
|
Blood Pressure | 4 | 2023 | 8554 | 0.160 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2020 | 370 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2016 | 9959 | 0.160 |
Why?
|
Waist Circumference | 3 | 2019 | 917 | 0.150 |
Why?
|
Cholesterol, LDL | 2 | 2017 | 2356 | 0.150 |
Why?
|
Dietary Carbohydrates | 2 | 2019 | 906 | 0.150 |
Why?
|
Nutrition Therapy | 1 | 2018 | 96 | 0.150 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 362 | 0.140 |
Why?
|
Cohort Studies | 5 | 2019 | 40561 | 0.140 |
Why?
|
Food, Formulated | 1 | 2016 | 109 | 0.130 |
Why?
|
Humans | 33 | 2024 | 744343 | 0.130 |
Why?
|
Dietary Fiber | 1 | 2019 | 760 | 0.130 |
Why?
|
Pregnant Women | 1 | 2019 | 568 | 0.120 |
Why?
|
Middle Aged | 14 | 2023 | 213383 | 0.120 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5181 | 0.120 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1312 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1536 | 0.110 |
Why?
|
Hyperinsulinism | 1 | 2016 | 415 | 0.110 |
Why?
|
Female | 19 | 2023 | 380194 | 0.110 |
Why?
|
Vitamin D Deficiency | 2 | 2014 | 1343 | 0.110 |
Why?
|
Glucose Intolerance | 2 | 2020 | 577 | 0.110 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2017 | 373 | 0.110 |
Why?
|
Dietary Fats | 1 | 2020 | 2017 | 0.100 |
Why?
|
Refugees | 1 | 2019 | 511 | 0.100 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2016 | 340 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 3255 | 0.100 |
Why?
|
Endocrine System Diseases | 1 | 2014 | 248 | 0.100 |
Why?
|
Male | 17 | 2023 | 350118 | 0.100 |
Why?
|
Body Mass Index | 4 | 2023 | 12720 | 0.100 |
Why?
|
Adult | 11 | 2020 | 214055 | 0.100 |
Why?
|
Diabetic Angiopathies | 1 | 2016 | 818 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2016 | 789 | 0.100 |
Why?
|
Income | 1 | 2019 | 1913 | 0.090 |
Why?
|
Incidence | 3 | 2014 | 20947 | 0.090 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2009 | 91 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2014 | 537 | 0.090 |
Why?
|
Venoms | 1 | 2009 | 91 | 0.090 |
Why?
|
Prediabetic State | 1 | 2014 | 499 | 0.080 |
Why?
|
Muscle, Skeletal | 2 | 2022 | 4931 | 0.080 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 941 | 0.080 |
Why?
|
Sulfonylurea Compounds | 1 | 2009 | 204 | 0.080 |
Why?
|
Aged | 9 | 2023 | 163280 | 0.080 |
Why?
|
Abdominal Fat | 1 | 2009 | 223 | 0.080 |
Why?
|
Fasting | 1 | 2014 | 1593 | 0.080 |
Why?
|
Coronary Disease | 1 | 2022 | 6077 | 0.070 |
Why?
|
Consensus | 1 | 2016 | 2959 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2011 | 12026 | 0.070 |
Why?
|
Life Style | 2 | 2018 | 3835 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2011 | 1344 | 0.070 |
Why?
|
Thiazolidinediones | 1 | 2009 | 476 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2017 | 1797 | 0.070 |
Why?
|
Administration, Inhalation | 1 | 2008 | 1105 | 0.070 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2009 | 293 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2013 | 21746 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5615 | 0.060 |
Why?
|
Benzamides | 1 | 2009 | 1379 | 0.060 |
Why?
|
Diet, Reducing | 2 | 2018 | 462 | 0.060 |
Why?
|
Regression Analysis | 1 | 2013 | 6459 | 0.060 |
Why?
|
Nutrition Surveys | 1 | 2010 | 1660 | 0.060 |
Why?
|
Metformin | 1 | 2009 | 835 | 0.050 |
Why?
|
Cholesterol, HDL | 2 | 2020 | 1814 | 0.050 |
Why?
|
Streptozocin | 1 | 2022 | 196 | 0.050 |
Why?
|
Uridine | 1 | 2022 | 146 | 0.050 |
Why?
|
United States | 3 | 2016 | 69872 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9146 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2716 | 0.050 |
Why?
|
Prospective Studies | 5 | 2022 | 53288 | 0.050 |
Why?
|
Health Status | 1 | 2014 | 4034 | 0.050 |
Why?
|
Anaerobic Threshold | 1 | 2020 | 52 | 0.050 |
Why?
|
Glucose | 2 | 2023 | 4397 | 0.050 |
Why?
|
Hospital Mortality | 2 | 2024 | 5317 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 10900 | 0.040 |
Why?
|
Albuminuria | 1 | 2023 | 682 | 0.040 |
Why?
|
Middle East | 1 | 2019 | 219 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9687 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10252 | 0.040 |
Why?
|
United Nations | 1 | 2019 | 165 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 452 | 0.040 |
Why?
|
Weight Loss | 1 | 2009 | 2622 | 0.040 |
Why?
|
Pregnancy | 1 | 2019 | 29144 | 0.040 |
Why?
|
Adolescent | 2 | 2019 | 85781 | 0.040 |
Why?
|
Arabs | 1 | 2019 | 178 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4409 | 0.040 |
Why?
|
Signal Transduction | 1 | 2020 | 23403 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15226 | 0.040 |
Why?
|
Seeds | 1 | 2016 | 105 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2170 | 0.030 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2016 | 226 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10397 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2022 | 1741 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2020 | 3701 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1484 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 7913 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 25043 | 0.030 |
Why?
|
Hyperparathyroidism | 1 | 2014 | 339 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1125 | 0.030 |
Why?
|
Graves Disease | 1 | 2014 | 242 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1677 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2018 | 865 | 0.030 |
Why?
|
Motor Activity | 1 | 2022 | 2714 | 0.030 |
Why?
|
Algorithms | 1 | 2012 | 13881 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2029 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2014 | 370 | 0.020 |
Why?
|
Counseling | 1 | 2018 | 1523 | 0.020 |
Why?
|
Lung | 1 | 2008 | 9856 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39050 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2401 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7186 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2020 | 3479 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 23338 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9849 | 0.020 |
Why?
|
Mice | 2 | 2022 | 81183 | 0.010 |
Why?
|
Rats | 1 | 2020 | 24260 | 0.010 |
Why?
|
Homeostasis | 1 | 2014 | 3340 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10262 | 0.010 |
Why?
|
Animals | 3 | 2022 | 168757 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3158 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8089 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 77449 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16365 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 57776 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12354 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 13989 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 63114 | 0.010 |
Why?
|
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_